Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Soligenix Inc (SNGX)

Soligenix Inc (SNGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,312
  • Shares Outstanding, K 40,104
  • Annual Sales, $ 2,360 K
  • Annual Income, $ -17,690 K
  • 60-Month Beta 1.31
  • Price/Sales 18.02
  • Price/Cash Flow N/A
  • Price/Book 2.83
Trade SNGX with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9100 +11.05%
on 08/25/21
1.2300 -17.84%
on 09/09/21
+0.0951 (+9.86%)
since 08/20/21
3-Month
0.8500 +18.89%
on 08/20/21
1.3200 -23.44%
on 07/06/21
-0.1050 (-9.77%)
since 06/18/21
52-Week
0.8500 +18.89%
on 08/20/21
2.8000 -63.91%
on 12/17/20
-0.9850 (-49.47%)
since 09/18/20

Most Recent Stories

More News
Soligenix to Advance Synthetic Hypericin Development in Psoriasis

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there...

SNGX : 1.0150 (-6.02%)
Soligenix Develops Groundbreaking Vaccine Platform to Target Future Pandemics

New York, New York--(Newsfile Corp. - September 14, 2021) - PCG Digital -- The COVID-19 pandemic has already cost the United States an estimated , and has resulted in the loss of over 600,000 lives. At...

SNGX : 1.0150 (-6.02%)
FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there...

SNGX : 1.0150 (-6.02%)
Soligenix: Developing Tools to Tackle the Next Potential Pandemic; PCG Digital Biotech Watch Review

/PRNewswire/ -- Vaccines are known for the stringent cold chain storage requirements necessary to maintain their integrity. In the U.S., maintaining refrigerated or frozen conditions is a simple logistical...

SNGX : 1.0150 (-6.02%)
Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there...

SNGX : 1.0150 (-6.02%)
Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there...

SNGX : 1.0150 (-6.02%)
Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is...

SNGXD : 4.1500 (-5.68%)
SNGX : 1.0150 (-6.02%)
BioFlorida Announces Five New Board Members

/PRNewswire/ -- BioFlorida has announced five new board members who will support the organization's effort to grow the life sciences industry in .

LGVN : 3.53 (-2.49%)
SNGX : 1.0150 (-6.02%)
Who Is Preparing Us for the Next Potential Pandemic?

New York, New York--(Newsfile Corp. - July 29, 2021) - -- PCG Digital -- Dr. Fauci said it publicly this week, but we've all been thinking it for months now. COVID-19 did not hit us, "out of the blue."...

SNGX : 1.0150 (-6.02%)
HyBryte(TM): Addressing an Unmet Need for Rare Lymphoma

New York, New York--(Newsfile Corp. - July 22, 2021) - PCG Digital -- Cutaneous T-cell lymphoma (CTCL) is a rare form of non-Hodgkin's lymphoma that currently affects between 16,000 - 20,000 Americans,...

SNGX : 1.0150 (-6.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable...

See More

Key Turning Points

3rd Resistance Point 1.1467
2nd Resistance Point 1.1133
1st Resistance Point 1.0967
Last Price 1.0150
1st Support Level 1.0467
2nd Support Level 1.0133
3rd Support Level 0.9967

See More

52-Week High 2.8000
Fibonacci 61.8% 2.0551
Fibonacci 50% 1.8250
Fibonacci 38.2% 1.5949
Last Price 1.0150
52-Week Low 0.8500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar